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Abstract: Drug-eluting stents are desirable platforms for local medicine delivery. However, the
incorporation of drugs into polymers can influence the mechanical and physicochemical properties
of said matrix, which is a topic that is still poorly understood. In fact, this is more noticeable since
the apposition is most often accompanied by mechanical stresses on the polymer coating, which
can induce therapeutic failure that can result in death. It is therefore necessary to better understand
their behavior by examining their properties in conditions such as those in living beings. We studied
polyurethane drug carriers made in-house. Diclofenac epolamine was chosen as a model hydrophilic
medicine. We used thermal measurements (DMTA) and tensile tests. The aim was to establish the
influence of the loading and release of the drug on the physicochemical properties of this polymer
in the presence of a stagnant or circulating fluid medium, phosphate-buffered saline (PBS). For the
two PU/drug loadings studied, the effect of the initial drug load was more marked. The free volume
fraction and the number of pores in the samples increased with the increasing percent of the drug and
with release time. The kinetic profiles were accelerated with the loading ratio and with the presence
of flow. Young′s modulus and ultimate stress were not significantly influenced by the release time. A
relevant relationship between the tensile properties and the viscoelastic behavior of the samples was
developed. Our results have implications for optimizing the performance of drug coatings for stents.
Keywords: drug-eluting stent (DES); polyurethane; mechanical properties; viscoelastic properties;
drug delivery; flow rate
1. Introduction
Polyurethane is the only type of polymer that can be in the categories of thermoplastics,
elastomers, and thermosets. It is synthesized from the reaction between polyols and
diisocyanates, wherein the choice of each polymer and the method of synthesis can drive it
into different categories [1]. For this reason, PUs are used for various applications, such as
adhesives, coatings, vehicle parts, sponge, implants and biological devices and organs [2].
In biomedical applications, PUs have also been used since they are biocompatible with
effective control over mechanical strength and flexibility [3]. By monitoring the construction
blocks and their final chemical composition, PUs may be made either biodegradable or
bioinert. By regulating the structure of PUs, these properties can be adjusted according
to the need. PUs can be classified as bioinert PUs and biodegradable PUs, the former of
which are used as artificial organs in medical devices and as drug delivery carriers, such as
drug-eluting stents (DESs).
Drug-eluting stents have altered therapeutic cardiology and resulted in a significant
advancement in the prevention of coronary artery restenosis [4]. Nevertheless, their usage
may lead to a delay in arterial wall healing, as well as endothelial function [5] and hypersen-
sitivity responses produced by polymers [6], as well as an increased risk of late acute stent
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thrombosis. Second-generation DESs, which are more biocompatible and biodegradable
polymers with different drug release formulations and designs, are related to a decrease
in intra-stent restenosis (ISR) and, consequently, a decrease in the incidence of late stent
thrombosis [7–9]. However, because of their permanent nature, they hinder the full re-
covery of vascular structure and function, raising the chance of stent failure very late [10].
Such fundamental restrictions with metal stents have encouraged the research community
to innovate bioresorbable stent scaffolds, where they are intended to be temporary and
disappear slowly, meanwhile providing vascular radial support. This is where the clinical
reports showed more incidence of thrombosis after some years of implantation [11,12].
In a study by Wang et al. [13], they analyzed the failure of bioabsorbable scaffold stents
(BRSs) and concluded that the polymeric microstructure from the initial steps of fabrication
should be considered. They stated that even before chemical degradation, stress produced
by crimping and inflation causes a loss of structural stability and variations in the poly-
mer microstructure, where inhomogeneity of the microstructure and degradation of the
polymer are the main reasons for this failure.
This issue is not just for the BRS, even the polymer used as a layer on the metal stent
as a drug carrier should possess the critical physical, mechanical and chemical properties
during release. Maintaining the proper physical and mechanical properties of the polymer
both in the case of the coating used for stenting and as the stent scaffold itself has been
very critical, where the ability to create a sustained release profile for drug release is part of
an important strategy to examine drug-eluting stents [14].
In this regard, to improve the design and properties, studies have analyzed polymeric
films [15,16], and the research has tried to improve the drug carrier′s properties and the
viscoelastic behavior of the polymer [17–21]. In this area, researchers have always tried to
obtain a more accurate estimate of the results by bringing the experimental environment
closer to the natural environment [22,23].
According to studies, the importance of the flow rate to the stress created on stents [24,25]
suggests that the presence of the flow rate creates a condition similar to the real condition.
The role of the flow on the physical and mechanical properties of the material in this field
of research has been emphasized.
Most polymer materials can possess the same necessary mechanical and non-toxic
properties as biological materials [26,27]. Therefore, whether polymer materials can be
used as medical materials generally depends on the biocompatibility of the materials
themselves [28,29].
In this study, the physical and mechanical properties of pure PU films and those loaded
with 10 and 20 wt% of a drug in static and dynamic conditions were investigated. The
importance of the free volume fraction, the viscoelastic behavior and the tensile properties
of PU films during the release time considering the two parameters of drug percentage and
flow rate was analyzed.
2. Materials and Methods
2.1. Materials
Polyurethane was synthesized by the mixture of polyisocyanate (Raigidur VX) and
polyol (Gyrothane 639) with the ratio of 2 to 5 according to the order in the notice. After
completely blending the mixture, it was poured gently into the mold and then heated in
the oven at a temperature of 50 ◦C for about 30 min to obtain the film of the polymer [25].
For the samples loaded with the drug, 10 or 20% (w/w) of the drug was added to
the polyol, and then a complete mixture hardener was added to the solution. Later, the
solution was cast in the mold covered with Teflon, followed by heating and drying. The
rectangular films were cut in the dimensions of 2 × 5 × 30 mm3.
The drug used in this study was diclofenac epolamine (DE) as an example of a hy-
drophilic active substance, with a molecular weight of 318.13, and phosphate-buffered saline
(PBS), which were purchased, respectively, from Genevrier Laboratory and Sigma Aldrich.
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2.2. Characterization Methods
2.2.1. Microscopic Observations
A scanning electronic microscope (SEM), HITACHI 4800, was used to qualitatively
investigate the material microstructure and especially the evolution of the polymer mor-
phology during the release test and fractography.
2.2.2. Dynamic Thermo-Mechanical Analysis (DMTA)
For DMTA tests, the apparatus Dynamic Mechanical Analyzer type Q800 V21.2 was used.
The dimensions of the rectangular specimens were approximately 30 × 5 × 2 mm3. The tests
were performed over the entire temperature range of the apparatus at −70 to 0 ◦C with the
step of 2.00 ◦C/min at multi-frequencies of 1, 2, 5, 10 and 30 Hz for calculation of the free
volume fraction and at a constant amplitude of 1 Hz for the Cole–Cole equation. The storage
and loss modulus were measured fitting to the temperature, and their corresponding values
were calculated in this way.
2.2.3. Mechanical Testing
Quasi-static tensile tests with a velocity of 5 mm/min were performed with an elec-
tromechanical and hydraulic system, an Instron 4301 machine, at the ambient temperature
to see the effects of drug percentage, flow rate and the release on the mechanical behavior
of the PU films. The time intervals chosen for the samples of the static and continuous state
were 0, 1, 12, 24 and 96 h.
2.3. In Vitro Drug Release Procedure and Associated Measurement
In this regard, a test bench (Figure 1) was prepared to perform the tests on static and
continuous states with different flow rates. At the static state, the prepared polymer films
with the mass ratio of 10% of DE to PU were immersed in the closed chamber with 10 mL
of phosphate-buffered saline (PBS) solution with a ratio of 60.0 mg/mL at 37 ◦C and pH 7.4.
The release results were obtained at certain time intervals; at each time step, 4 mL was
sampled for analyzing, and 4 mL of fresh PBS was added to the solution.
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Figure 1. Schematic of the test bench.
In the continuous state, the test bench could rotate the solution with the defined flow
rate of 7.5 mL/s, which was controlled by a home-designed code in the LabView program.
The sample was placed in the chamber and from one side it was in contact with the flow
medium and the other side with a rigid surface. In order to avoid the moving of the sample
by the flow, it was fixed with clamps. This test bench had a reservoir that contained 1 L of
PBS, and, at each time step, 4 mL of the solution was sample . The buffe soluti was
maintained at the temperature of 37 ◦C and the pH of 7.4. Figure 1 shows the schematic of
the test bench.
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The ultraviolet–visible (UV–Vis) spectrophotometer Lambda 35 was used to determine
the concentration of diclofenac in the PBS solution. To calculate the accumulative release
percentage of the drug, the total amount of diclofenac loaded to the PU was also measured
after completely degrading the polymer film in the ultrasound. To establish the calibration
curve of the measurements, the known concentrations of DE in the PBS were measured.
The following calibration equation was found with the correlation coefficient of R2 = 0.999.
3. Results
3.1. The Effect of Flow Rate and Drug Percentage on the Drug Release
The objective of this study is to analyze the capacity of PU films as a drug delivery car-
rier and the evolution of polymer properties, such as physical, mechanical and viscoelastic
behavior, considering the two different parameters of flow rate and drug percentage. At
first, the results of the drug release in different conditions are presented. Figure 2 shows the
drug release from the polyurethane samples at the static and continuous flow, with 10 and
20% of drug loading. The release profile for each case consists of two stages, respectively,
burst release and extended release [30].
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Figure 2. Cumulative drug release curves (a) at the fl te of 0 and 7.5 mL/s and (b) PU-10%DE and PU-20%DE at the
flow rate of 7.5 mL/s (PU-10%-DE-Q7.5: polyurethane-10% i ac epolamine—flow rate of 7.5 mL/s).
Figure 2a shows that increasing the flow rate decreases the overall time of the release.
Moreover, it is notable that by changing the state of the flow from static to continuous, the
amount of burst release is increased, which clearly shows that the burst phenomenon is
related to convection. The second stage of the release, which is almost continued with the
mechanism of diffusion, is slower for the flow rate of zero compared to 7.5 mL/s. This
can be due to the high-water uptake by the polymer film when the flow rate increases.
Moreover, in the st tic state, the drug is not able to migrate far away from the s mple
(thick mass boundary layer and low concentrati n gradients leading to l w diffusive flux),
whereas in the continuous state, the released drug is immediately transported by the flow
(thin mass boundary layer and high concentration gradients leading to high diffusive flux).
The former results reveal that the mechanism of diffusion is not irrelevant to the flow
rate. This difference implies the effect of the gradient of concentration. One can consider
the release at time t (shown in Figure 3) for the static and continuous states wherein the
circulating medium, the gradient always stays high between the samples and the medium;
however, in the static, although the medium is not saturated, the gradient will be low at
time t + ε. One can note from the r lease curves that t e sam ph nomena of rel ase occur
for t e cases with different flow rates, w ere accelerat ng the flow increases the k netics
and speeds up the phenomena. It is notable that in the static state, the method was the
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incubation method, and two surfaces of the samples were in contact with the dissolution
medium, but in the continuous state, just one side was in contact with the dissolution
medium. Therefore, this emphasizes the importance of the flow rate on the release.
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Figure 2b indicates that by increasing the initial drug load, the drug percentage released
during the release test is higher, especially during the first stage, which is probably due to
the presence of more drug particles on the surface, which results in the burst release of the
drug. As mentioned in [31], the physicochemical properties of the active substance affect
their distribution in the polymeric matrix, wherein it is more probable for the hydrophilic
active substance to move toward the surface of the polymer. Therefore, the hydrophilic
active substance that has more tendency to stay near the surface is more likely to result
in burst release wherein the drug is released by desorption at the initial periods [31]. In
addition, increasing the hydrophilic drug particles increases the water absorption, which is
the requirement for th dru rel ase f m polymeric films. Therefore, incr asing the drug
percentage increases th rate of the release.
However, Figur 2b shows that at the second stage, the kinetics of the release decreases,
and PU-10% and PU-20% are depleted from the drug at nearly t same time, but PU-10%
comparatively pursues slower kinetics. It is observed from the release profiles that after
the burst release, where the release is controlled by the diffusion phenomenon, the kinetics
of the release decreases. This can be due to the higher initial burst release, which results in
the gradient of the concentration decreasing and the slower kinetics of diffusion. The main
reason for this can be explained by the scanning electron micrographs shown in Figure 4
from the side and surface of the samples, where increasing the drug percentage increases
the pores in the structure of the samples. In addition, the possibility of the canalization
between the pores contributes to the increased drug release.
Studies have concluded that apart from the external elements, the release behavior of
the carriers is basically influenced by the polymeric structure and properties of the carriers.
The subsequent results discuss these properties by considering the effect of two parameters,
drug percentages and flow rate.
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3.2. Polymer Properties Evolution during Drug Release
3.2.1. Free Volume Fraction Evolution of PU
In a polymer, free volume can b determine by the volume of the total mass, which
is not occupie by polymer chains and can therefore be a favorable place for the diffusing
molecules, which can affect the permeability of the polymer membrane. Normally, the
space or pores formed between the polymer chains are assumed to be the free volume
fraction in the polymer. These free volumes are randomly distributed in the polymer,
which reflects the movements of the polymer chains and, therefore, the transport of the
molecules and, on th whole, the performance of the polymer membrane. It is difficult to
analyze the pores directly in the membrane since the differ nces exist on a molecular scale.
It is an inherent roperty that is temporary and varia le, where the polymer′s physical
state and density significantly affect its value. The mechanism of reducing the extra free
volume of the membrane can be linked to physical aging, arising from the contraction
of the lattice and the migration and diffusion of the free volume from the inside of the
membrane to the surface [32]. These explanations reveal the importance of the polymer
structure in the kinetics of the drug release. There are some studies that show the effect of
the porous structure and the importance of the free volume fraction in drug release [33].
The polyurethane used in this study is an elastomer where in the structure small holes as
the free volume are created. The effect of this parameter is investigated for the PU films
without the drug a d with 10 and 20% of the drug and its influence on the release behavior.
Figure 5 represents a schematic of the free volume fraction in the polymers.
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The Williams–Landel–Ferry (WLF) equation is one of the most used equations in
polymer systems to calculate the free volume fraction in polymer membranes [34,35]. It
is principally utilized to predict the mechanical properties of the material out of the time
range of the experimental test.
The frequency of the applied loading affects the viscoelastic behavior of the polymer.
This dependence between temperature and viscosity is proportional to the frequency and
also the correlating relation. It describes the temperature dependence of the molecular
relaxation times in the glass-forming substances at the glass transition temperature Tg [36].
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It is notable from the results that the drug percentages change the free volume frac-
tion of the polymer, as by increasing the drug percentage, the free volume fraction slightly 
increases. One can conclude that the effect of the drug concentration on the variation of 
polymer molecules in mixing should be considered, where it needs to be combined with 
the effect of the free volumes of the constituent solvent, polymer and drug in a polymer 
carrier film in determination of its thermodynamic properties. 
3.2.2. Mechanical Properties of PU Samples 
Figure 7a,b shows the tensile curves of the PU samples with 0 and 10% of the drug at 
different times of incubation in the static state. The results show that the effects of the drug 
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Therefore, the values of the free volume fraction coefficient using fg =
√
((B.∆α.A)/2.303)
for PU, PU-10% DE and PU-20% DE are calculated, respectively, at about 0.37× 10−2, 0.47× 10−2
and 0.5 × 10−2.
It is notable from the results that the drug percentages change the free volume fraction
of the polymer, as by increasing the drug percentage, the free volume fraction slightly
increases. One can conclude that the effect of the drug concentration on the variation of
polymer molecules in mixing should be considered, where it needs to be combined with
the effect of the free volumes of the constituent solvent, polymer and drug in a polymer
carrier film in determination of its thermodynamic properties.
3.2.2. Mechanical Properties of PU Samples
Figure 7a,b shows the tensile curves of the PU samples with 0 and 10% of the drug at
different times of incubation in the static state. The results show that the effects of the drug
on the mechanical properties of the polymeric samples are significant. Figure 7a shows
that the immersion time for the pure PU samples does not significantly change the tensile
properties. However, Figure 7b indicates that increasing 10% of the drug decreased the
mechanical properties to about half. Moreover, the presence of the drug causes the variation
of the mechanical properties during the release time compared to the pure polymer. This
can be due to the free volume and the pores created in the samples and the low bindings
between the polymer chains due to the presence of the drug particles.
Figure 7c–e show the tensile behavior of the PU samples with 0, 10 and 20% of the
drug at the flow rate of 7.5 mL/s. The results from these figures show that adding 10%
of the drug decreases the mechanical properties to about half and adding 20% of the drug
decreases them to about a quarter of the pure PU values. One can note from comparisons
between Figure 7a,c as well as between Figure 7b,d that the flow rate of 0 and 7.5 mL/s for
PU-Pure, stress and strain drops from 3.95 to 3.36 MPa and from 330 to 269, which shows
that the effect of the flow rate on the mechanical behavior is not highly noticeable for this
kind of polymer. Additionally, the mechanical properties of the PU samples with 0, 10 and
20% of the active substance before positioning in the fluid show the high effect of the drug
load in the properties of the carriers (shown in Figure 7c–e). This indicates that adding the
active substance results in low elasticity of the polymer carrier. After the initial contact of the
drug-charged samples with the aquas medium (1 h) and the water absorption of the active
substance and the polymer, the carrier becomes more deformable (shown in Figure 7d,e).





Figure 6. (a) Multi-frequency DMTA tests: glass transition temperature evolution (PU-10% DE) and 
(b) linear r gress on of WLF equation. 
Therefore, the values of the free volume fraction coefficient using f =((B. ∆α. A)/2.303) for PU, PU-10% DE and PU-20% DE are calculated, respectively, at 
about 0.37 × 10−2, 0.47 × 10−2 and 0.5 × 10−2. 
It is notable from the results that the drug perc ntages change the free volume frac-
tion of the polymer, as by increasing the drug perc ntag , the ree vol me fraction sligh ly 
increases. One can conclude that the eff ct of the drug concentration on the variation of 
polym r molecul s in mixing should be con idered, where it needs to be combined with 
the eff ct of the free volume  of the constitue t solvent, polymer and drug in a polymer 
carrier film in determina ion of its th rmodynamic properties. 
3.2.2. Mechanical Properties of PU S mples 
Figure 7a,b shows the tensile curves of the PU samples with 0 and 10% of the drug at 
different times of incubation in the static state. The results show that the effects of the drug 
on the mechanical properties of the polymeric samples are significant. Figure 7a shows 
that the immersion time for the pure PU samples does not significantly change the tensile 
properties. However, Figure 7b indicates that increasing 10% of the drug decreased the 
mechanical properties to about half. Moreover, the presence of the drug causes the varia-
tion of the mechanical properties during the release time compared to the pure polymer. 
This can be due to the free volume and the pores created in the samples and the low bind-










Figure 7. Stress–strain curves of (a,c) pure PU, (b,d) PU-10%DE and (e) PU-20%DE samples at dif-
ferent flow rates (PU-10%DE-Q7.5: polyurethane-10% diclofenac epolamine—flow rate of 7.5 mL/s). 
Figure 7c–e show the tensile behavior of the PU samples with 0, 10 and 20% of the 
drug at the flow rate of 7.5 mL/s. The results from these figures show that adding 10% of 
the drug decreases the mechanical properties to about half and adding 20% of the drug 
decreases them to about a quarter of the pure PU values. One can note from comparisons 
between Figure 7a,c as well as between Figure 7b,d that the flow rate of 0 and 7.5 mL/s for 
PU-Pure, stress and strain drops from 3.95 to 3.36 MPa and from 330 to 269, which shows 
that the effect of the flow rate on the mechanical behavior is not highly noticeable for this 
kind of polymer. Additionally, the mechanical properties of the PU samples with 0, 10 
and 20% of the active substance before positioning in the fluid show the high effect of the 
drug load in the properties of the carriers (shown in Figure 7c–e). This indicates that add-
ing the active substance results in low elasticity of the polymer carrier. After the initial 
contact of the drug-charged samples with the aquas medium (1 h) and the water absorp-
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in Figure 7d,e). 
Figure 8a–f show the comparison of the modulus, the ultimate strength and strain at 
break values for the different percentages of the drug (0, 10 and 20%) at different time 
intervals of the static and continuous release tests. The results from Figure 8a,b show that 
the effect of the drug percentage on the mechanical behavior of the samples is more sig-
nificant in comparison to the flow rate, where the increase in drug percentage decreases 
the Young modulus value. The results show that the time of incubation slightly decreases 
the value of the modulus, where this effect is more visible for the charged polymers than 
for the pure polymers. Figure 8c,d show the ultimate strength of the PU with different 
Figure 7. Stress–strain curves of (a,c) pure PU, (b,d) PU-10%DE and (e) PU-20 DE sa ples at differ-
ent flow rates (PU-10%DE-Q7.5: polyurethane-10% diclofenac epolamine—flow rate of 7.5 mL/s).
Figure 8a–f show the comparison f the modulus, th ult mate stre gth and s rain
at break values for the different percentages f the drug (0, 10 and 20%) t ifferent time
intervals of the tatic and continuous rel ase tests. The results from Figure 8a,b show
that the effect of the drug pe centage on the mechanical behavior of the samples is more
significant in comp rison to th flow rate, where the increase in drug percentage decreases
the Young modulu value. The results show that the time of incubati n slightly decreases
the value of the modulus, where this ffect is more visible for t e charged polyme s than
for the pure polymers. Figure 8c,d show the ultimate strength of the PU with different
percentages of the drug at the flow rates of 0 and 7.5 mL/s. By comparing t ese values, the
impact of the flow rate and the time of incubation is not significant; however, increasing
the initial load of the drug greatly decreases the ultimate strength of the PU samples. The
variance in strength during the initial incubation ti e can be due to the plasticizing effect
of the water molecules on the components of the DDS. Figure 8e,f show the strain at break
for the PU with a different percentage of the drug at the flow rates of 0 and 7.5, respectively.
Comparing the results of the strain at break for the PU shows that increasing the drug
percentage decreases the elongation of the polymeric samples. However, elongation of
the samples along with the incubation time does not differ significantly, but, because of
the plasticizing after 96 h, it has a slight increase. From the mechanical results, one can
observe that the highest modulus, stress and elongation at break among all the results
with/without the drug before or after the test refers to the virgin pure PU. PU-20%DE before
the incubation test has the lowest value of the stress and strain. This can be explained
because as the percentages of the drug increase, the number of pores in the samples
increases, which results in the decrease in the mechanical properties, whereas the flow rate
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does not remarkably affect the mechanical properties of the samples. The results show
that by increasing the flow rate, the kinetics of the drug release is increased; however, this
parameter does not significantly change the intrinsic properties of the material, such as
the Tg and modulus, where the drug percentages change the mechanical properties of the
polymer and increase the free volume fraction in the samples.
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proposed to predict these properties. These models generally represent the curve of 𝐸” 
(loss modulus) as a function of 𝐸′ (storage modulus), and the curve is known as the Cole–
Cole diagram [37]. Moreover, it describes the relaxation times and the temperature effect 
on viscosities. It is used to describe the dielectric relaxation of a material, which refers to 
the relaxation of a polymer when applying an external load. The changes in frequencies 
affect the viscoelastic properties because it has a direct effect on molecular architecture. In 
fact, when applying an oscillatory load, the macromolecule movements in the free volume 
present in the material system cause new overlaps with neighboring chains. This transfor-
mation carries out a significant role in the time of the relaxation phenomenon, which in-
creases with the frequency. The diagram below (Figure 9) illustrates the different steps of 
this work. 
Figure 8. Tensile properties: (a,b) modulus, (c,d) ltimate strength and (e,f) strai at break of PU samples with different
percentages of DE after release test in the static and continuous states.
From the mechani l results, one can observe the higher modulus, t ength and strain
failure are related to the samples without the drug, where increasing the drug percentages
decreases all mechanical properties of this type of polymeric material. This can be explained
by the SEM figures, because as the percentage of the drug increases, the number of pores in
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the samples increases, which results in the decrease in the mechanical properties, whereas
the flow rate does not affect the mechanical properties of the samples.
3.2.3. Modeling of the Viscoelastic Behavior by the Cole–Cole Principle
Various approaches have been used to study the viscoelastic properties in the tem-
perature range between the glassy and rubbery domain, and different models have been
proposed to predict these properties. These models generally represent the curve of E
′′
(loss
modulus) as a function of E′ (storage modulus), and the curve is known as the Cole–Cole
diagram [37]. Moreover, it describes the relaxation times and the temperature effect on
viscosities. It is used to describe the dielectric relaxation of a material, which refers to
the relaxation of a polymer when applying an external load. The changes in frequencies
affect the viscoelastic properties because it has a direct effect on molecular architecture.
In fact, when applying an oscillatory load, the macromolecule movements in the free
volume present in the material system cause new overlaps with neighboring chains. This
transformation carries out a significant role in the time of the relaxation phenomenon,
which increases with the frequency. The diagram below (Figure 9) illustrates the different
steps of this work.
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The polarization magnitude of a material is defined by the dielectric constant repre-
sented by the equations of Debye and Onsager [38]. The single relaxation peak is inappro-
priate to reasonably describe the viscoelastic behavior of polymers. Cole–Cole is an ap-
propriate treatment of dielectric relaxation data marked by plotting 𝐸′′ versus 𝐸′ [39]; 
each point corresponds to one frequency [40]. Structural changes occurring in cross-linked 
polymer materials can be carried out using the Cole–Cole principle. 
For the validation of the theoretical model, experimental data obtained by the DMTA 
tests were required. After these tests, an asymmetric Cole–Cole diagram was plotted (Fig-
ure 10). 
(a)
Figure 9. Flowchart diagra indicating the different steps of odeling (E∗: complex modulus, E
′′
:
loss modulus, E′: storage modulus, δ phase lag between stress and strain).
The polarization magnitude of a material is defi e t i l -
res nted by the equati ns of Debye a d Onsager [38]. The single relaxation peak is
inappropriate to reasonably describe the viscoelastic behavior of polymers. ole–Cole is
an appropriate treatment of dielectric relaxation data marked by plotting E
′′
versus E′ [39];
each point corresponds to one frequency [40]. Structural changes occurring in cross-linked
polymer materials can be carried out using the Cole–Cole principle.
For the validation of the theoretical model, experimental data obtained by the DMTA tests
were required. After these tests, an asymmetric Cole–Cole diagram was plotted (Figure 10).
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the slope of the tangents at the beginning and the end of the Cole–Cole diagram (dE′′/ dE′), 
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cates decreased molecular mobility [43]. k′ describes the difficulty with which local shear 
is developed. The mobility of polymer chains becomes slower as k′ decreases [44]. The 
parameter Q is a function of the concentration of quasi-punctual defects, and it is related 
to the maximum value of E′′, which is higher when Q is lower. The parameter τ is re-
lated to the chain relaxation time, describing the time taken by the structural unit to move 
at a distance comparable to that of its dimensions to return to its thermodynamic equilib-
rium. Indeed, the molecular mobility decreases with the temperature, and this decrease 
corresponds to the decrease in thermal activation but also to the increasingly marked co-
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where E∞ is the shear modulus corresponding to the rubbery state, and E0 corresponds
to the modulus at the glassy state. Each transition is described by a pair of (E0, E∞).
k and k′ are identified with the slope of (dE
′′
/dE′), from both sides of the curve. k
indicates the intensity of the correlation effects occurring during the expansion of the
molecules (changes in shape, area and volume) and the molecular motion; a rise in
this value indicates decreased molecular mobility [43]. k′ describes the difficulty with
which local shear is developed. The mobility of polymer chains becomes slower as k′
decreases [44]. The parameter Q is a function of the concentration of quasi-punctual
defects, and it is related to the maximum value of E
′′
, which is higher when Q is lower.
The parameter τ is related to the chain relaxation time, describing the time taken by
the structural unit to move at a distance comparable to that of its dimensions to return
to its thermodynamic equilibrium. Indeed, the molecular mobility decreases with the
temperature, and this decrease corresponds to the decrease in thermal activation but
also to the increasingly marked cohesion when the temperature decreases (decrease
in enthalpy, entropy of configuration and specific volume); the rearrangement time
becomes very long compared to these local movements. The values of the model′s
parameters are shown in Table 1.
Table 1. Perez model parameters for PU and PU-10% and PU-20% of diclofenac at different release
times at the flow rate of 7.5 mL/s (f = 1 Hz).
Samples E∞ (MPa) E0 (MPa) k k
′ Q τ (s)
PU-Pure-0 h 16 2690 0.41 0.23 2 0.5
PU-10%-0 h 14 2200 0.4 0.25 1.2 1
PU-10%-12 h 13 1715 0.37 0.24 2 2
PU-10%-24 h 12 1519 0.37 0.25 2.4 3
PU-10%-96 h 11 1100 0.45 0.3 3 4
PU-20%-0 h 14 2050 0.24 0.3 2 5
PU-20%-12 h 12 1368 0.24 0.34 2 6
PU-20%-24 h 10 1180 0.24 0.34 2 7
PU-20%-96 h 7 1040 0.25 0.35 2 8
The theoretical curve fits perfectly with the experimental results (Figure 10), signifying
that the bi-parabolic model can accurately predict the viscoelastic behavior of PU. One can
note that the viscoelastic behavior of PU (with 0, 10 and 20% of DE) obeys the Perez model.
This confirms the importance of the matrix in the behavior of PU with and without the drug.
One can note from Table 1 that the elastic modulus for the pure PU is higher; however,
by increasing the drug percentage and the release time, the elasticity of the samples decreases.
The same logic is shown for the viscous modulus wherein the pure PU is higher, and by
increasing the drug percentage and release time, it decreases.
Moreover, analysis of the results obtained shows that by increasing the drug percent-
age, the value of k decreases, which indicates the faster motion of the molecules.
Furthermore, k and k′ decreases with the increasing viscosity and compactness of the
samples; therefore, it is observed from Table 1 that the samples of PU-20% at the times 0,
12 and 24 h have the same value, and this value increases when the time of the release is
increased to 96 h. One can observe that by increasing the drug percentage and the release
time, the relaxation time increases.
The evolution of storage and loss moduli and the relaxation time at different times of
release can be analyzed for each drug percentage. Figure 11 shows these curves. One can
observe from Figure 11a,b the decrease in viscous and elastic moduli. The relationship of the
release time and these parameters shows an exponential equation type y = a− b× ct. The
latter is observable for both 10 and 20% of the initial drug loaded. The effect of the initial
drug load on the equation of the viscous modulus has a double increase on the parameters
of “a” and “b” when increasing the drug from 10 to 20%. The former shows that there
is a direct relationship between these parameters and the drug percentage. However, as
Polymers 2021, 13, 2608 14 of 17
presented in Table 2, the variables of the equation for the elastic modulus do not change
remarkably for neither 10 nor 20%, where it indicates less dependence of the elastic modulus
on the drug percentage.
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increased during the release time. The effect of the initial drug load on the equation of the 
relaxation time shows a double increase on the parameter “a” of the exponential equation. 
This analysis can be used to predict the viscoelastic behavior of the samples with 
different drug percentages during the release phenomenon. 
4. Conclusions 
Understanding the influence of the parameters of a drug on the behavior of the car-
rier polymer matrix and vice versa is of major interest, particularly in the field of drug-
eluting stents. In this study, PU/drug samples were investigated in vitro regarding the 
influence of the drug loading ratio and the presence or not of PBS circulation on the 
Figure 11. Relationship between the values of (a) elastic and (b) viscous modulus and (c) relaxation
time with the time of release and drug percentage.
Table 2. Parameters of the relationship between the values of elastic and viscous modulus and
relaxation time with the time of release and drug percentage.
Drug Percentage Parameters of Equation a b c R2
10%
E0 (MPa) 10.291 −3.747 0.97 0.997
E∞(MPa) 1086.214 1103.039 0.959 0.996
τ (s) 4.129 3.129 0.967 0.984
20%
E0 (MPa) 5.876 −8.194 0.973 0.998
E∞(MPa) 1048.920 998.835 0.912 0.999
τ (s) 8.051 3.051 0.958 0.991
Moreover, the investigation about the relaxation time shows that relaxation time is
increased during the release time. The effect of the initial drug load on the equation of the
relaxation time shows a double increase on the parameter “a” of the exponential equation.
This analysis can be used to predict the viscoelastic behavior of the samples with
different drug percentages during the release phenomenon.
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4. Conclusions
Understanding the influence of the parameters of a drug on the behavior of the carrier
polymer matrix and vice versa is of major interest, particularly in the field of drug-eluting
stents. In this study, PU/drug samples were investigated in vitro regarding the influence
of the drug loading ratio and the presence or not of PBS circulation on the thermal and
mechanical properties of the polymer matrix. Diclofenac epolamine was blended with PU
in ratios of 0, 10 and 20 w/w% with respect to the polymer. Our results showed that by
increasing the flow rate, the kinetics of the drug release increased; however, this parameter
did not significantly change the intrinsic properties of the material, such as the mechanical
properties. In contrast, an increase in the drug percentage increases the kinetics of the release,
changes the tensile properties of the polymer and increases the free volume fraction in the
samples. Thus, the higher mechanical properties refer to the polyurethane without the drug,
whereas the lower mechanical properties refer to the loaded polyurethane samples before
the drug liberation. The viscoelastic properties of the samples were additionally affected
by increasing the drug percentage and the release time; the elastic and viscous modulus
decreases whereas relaxation time increases. It is notable that these characteristics follow an
exponential relationship with time release.
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